The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC
Open accessAbstract
Hepatocellular adenomas are benign tumors that can be difficult to diagnose. To refine their classification, we performed a comprehensive analysis of their genetic, pathological, and clinical features. A multicentric series of 96 liver tumors with a firm or possible diagnosis of hepatocellular adenoma was reviewed by liver pathologists. In all cases, the genes coding for hepatocyte nuclear factor 1α (HNF1α) and β-catenin were sequenced. No tumors were mutated in both HNF1α and β-catenin enabling tumors to be classified into 3 groups, according to genotype. Tumors with HNF1α mutations formed the most important group of adenomas (44 cases). They were phenotypically characterized by marked steatosis ( P < 10−4), lack of cytological abnormalities ( P < 10−6), and no inflammatory infiltrates ( P < 10−4). In contrast, the group of tumors defined by β-catenin activation included 13 lesions with frequent cytological abnormalities and pseudo-glandular formation ( P < 10−5). The third group of tumors without mutation was divided into two subgroups based on the presence of inflammatory infiltrates. The subgroup of tumors consisting of 17 inflammatory lesions, resembled telangiectatic focal nodular hyperplasias, with frequent cytological abnormalities ( P = 10−3), ductular reaction ( P < 10−2), and dystrophic vessels ( P = .02). In this classification, hepatocellular carcinoma associated with adenoma or borderline lesions between carcinoma and adenoma is found in 46% of the β-catenin–mutated tumors whereas they are never observed in inflammatory lesions and are rarely found in HNF1α mutated tumors ( P = .004). In conclusion , the molecular and pathological classification of hepatocellular adenomas permits the identification of strong genotype–phenotype correlations and suggests that adenomas with β-catenin activation have a higher risk of malignant transformation. (Hepatology 2006;43:515–524.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data
Ramakers, C., Ruijter, J. M., Deprez, R. H. L., & Moorman, A. F. M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01423-4 · Cited by 3,709
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Terminology of nodular hepatocellular lesions
Wanless, I. R. (1995) · Hepatology · doi:10.1002/hep.1840220341 · Cited by 1,130
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Self-citationHuber, A. H., & Weis, W. I. (2001) · Cell · doi:10.1016/s0092-8674(01)00330-0 · Cited by 777
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Self-citationMiyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., & Nakamura, Y. (1998) · PubMed · Cited by 432
New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
Cadoret, A., Ovejero, C., Terris, B., Souil, E., Lévy, L., Lamers, W. H., Kitajewski, J., Kahn, A., & Perret, C. (2002) · Oncogene · doi:10.1038/sj.onc.1206118 · Cited by 410
Bi-allelic inactivation of TCF1 in hepatic adenomas
Bluteau, O., Jeannot, E., Bioulac-Sage, P., Marqués, J. M., Blanc, J.-F., Bui, H., Beaudoin, J.-C., Franco, D., Balabaud, C., Laurent-Puig, P., et al. (2002) · Nature Genetics · doi:10.1038/ng1001 · Cited by 353
Self-citationNhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., & Buendia, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65168-1 · Cited by 295
Self-citationFléjou, J., Barge, J., Menu, Y., Degott, C., Bismuth, H., Potet, F., & Benhamou, J. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90220-3 · Cited by 279
Wanless, I. R., Albrecht, S., Bilbao, J., Frei, J., Heathcote, E. J., Roberts, E. A., & Chiasson, D. A. (1989) · PubMed · Cited by 234
Monga, S. P. S., Monga, H. K., Tan, X., Mulé, K., Pediaditakis, P., & Michalopoulos, G. K. (2003) · Gastroenterology · doi:10.1053/gast.2003.50000 · Cited by 221
Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma
Paradis, V., Benzekri, A., Dargère, D., Bièche, I., Laurendeau, I., Vilgrain, V., Belghiti, J., Vidaud, M., Degott, C., & Bedossa, P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.005 · Cited by 208
Self-citationYamamoto, Y., Sakamoto, M., Fujii, G., Tsuiji, H., Kenetaka, K., Asaka, M., & Hirohashi, S. (2003) · Hepatology · doi:10.1053/jhep.2003.50029 · Cited by 200
Bioulac-Sage, P., Rebouissou, S., Sa Cunha, A., Jeannot, E., Lepreux, S., Blanc, J.-F., Blanché, H., le Bail, B., Saric, J., Laurent-Puig, P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.004 · Cited by 199
Self-citationβ-Catenin is temporally regulated during normal liver development☆
Micsenyi, A., Tan, X., Sneddon, T., Luo, J.-H., Michalopoulos, G. K., & Monga, S. P. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.047 · Cited by 191
Bacq, Y., Jacquemin, E., Balabaud, C., Jeannot, E., Scotto, B., Branchereau, S., Laurent, C., Bourlier, P., Pariente, D., De Muret, A., et al. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.012 · Cited by 184
Self-citationChen, Y., Jeng, Y., Yeh, S., & Chen, P. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00099-x · Cited by 147
Reznik, Y., Dao, T., Coutant, R., Chiche, L., Jeannot, E., Clauin, S., Rousselot, P., Fabrè, M., Oberti, F., Fatome, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031552 · Cited by 140
Self-citationGermline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas
Rebouissou, S., Vasiliu, V., Thomas, C. G., Bellanné‐Chantelot, C., Bui, H., Chrétien, Y., Timsit, J., Rosty, C., Laurent‐Puig, P., Chauveau, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi057 · Cited by 119
Self-citationHepatocyte nuclear factor 1 alpha (HNF-1?) mutations in maturity-onset diabetes of the young
Ellard, S. (2000) · Human Mutation · doi:10.1002/1098-1004(200011)16:5<377::aid-humu1>3.0.co;2-2 · Cited by 117
Hepatic Adenomas: Analysis of Sex Steroid Receptor Status and the Wnt Signaling Pathway
Torbenson, M. S., Lee, J.-H., Choti, M. A., Gage, W. R., Abraham, S. C., Montgomery, E., Boitnott, J., & Wu, T. (2002) · Modern Pathology · doi:10.1038/modpathol.3880514 · Cited by 94
Sex hormones and hepatic neoplasia.
Goldfarb, S. (1976) · PubMed · Cited by 93
Bala, S., Wünsch, P. H., & Ballhausen, W. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041254 · Cited by 74
Bläker, H., Sutter, C., Kadmon, M., Otto, H. F., Doeberitz, M. V. K., Gebert, J. F., & Helmke, B. M. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20071 · Cited by 60
Cited by
Mazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Self-citationGenetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Self-citationNault, J. C., Mallet, M., Pilati, C., Calderaro, J., Bioulac-Sage, P., Laurent, C., Laurent, A., Cherqui, D., Balabaud, C., & Zucman-Rossi, J. (2013) · Nature Communications · doi:10.1038/ncomms3218 · Cited by 695
Self-citationLadeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S., & Zucman-Rossi, J. (2008) · Hepatology · doi:10.1002/hep.22256 · Cited by 684
Self-citation
Metadata
- Authors
- Zucman-Rossi, J., Jeannot, E., Van Nhieu, J. T., Scoazec, J.-Y., Guettier, C., Rebouissou, S., Bacq, Y., Leteurtre, E., Paradis, V., Michalak, S., Wendum, D., Chiche, L., Fabre, M., Mellottee, L., Laurent, C., Partensky, C., Castaing, D., Zafrani, E. S., Laurent-Puig, P., Balabaud, C., & Bioulac-Sage, P.
- Venue
- Hepatology
- Published
- 2006-03
- Volume
- 43
- Issue
- 3
- Pages
- 515-524
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1983292214
- Cited by
- 760
- References
- 29
- FWCI
- 24.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.